Key Segments:
By Component
-
Photosensitizing Drugs
-
Light-Delivery Devices
-
Dosimeter
-
Planning Software & Accessories
-
Treatment & Maintenance Services
-
Others
By Light Source
-
Laser-Based Systems
-
LED-Based Systems
-
Daylight Photodynamic Therapy
-
Others
By Application
-
Actinic Keratosis & Precancerous Skin Lesions
-
Non-Melanoma Skin Cancer
-
Oncology Applications
-
Acne & Other Dermatological Conditions
-
Ophthalmology
By End User
-
Dermatology Clinics
-
Hospitals & Cancer Centers
-
Specialty Oncology Centers
-
Ambulatory & Outpatient Centers
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Photodynamic Therapy Market was valued at USD 3.16 Billion in 2025.
The market is anticipated to expand at a CAGR of 7.47% during the forecast period.
Photosensitizing Drugs accounted for the largest revenue share of 38.00% in 2025.